Home › Funds › Geode Capital Management › AVBP
Geode Capital Management position in AVBP
ARRIVENT BIOPHARMA INC · Health Care
Latest position (Q2 2026)972.63K sh
Reported value held$33.80M
Portfolio Weight0.00%
First reportedQ1 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 225.05K | $4.02M | New |
| Q2 2024 | 234.94K | $4.36M | Add |
| Q3 2024 | 597.16K | $14.04M | Add |
| Q4 2024 | 596.18K | $15.89M | Hold |
| Q1 2025 | 614.52K | $11.37M | Add |
| Q2 2025 | 596.02K | $12.98M | Reduce |
| Q3 2025 | 716.29K | $13.22M | Add |
| Q4 2025 | 753.52K | $15.16M | Add |
| Q1 2026 | 803.65K | $18.54M | Add |
| Q2 2026 | 972.63K | $33.80M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AVBP
- Hillhouse Capital (HHLR Advisors) 3.93M sh · $136.50M · Q2 2026
- BlackRock Inc 3.25M sh · $112.92M · Q2 2026
- Fidelity Management & Research (FMR) 2.78M sh · $96.54M · Q2 2026
- Vanguard Group 1.87M sh · $37.61M · Q4 2025
- D. E. Shaw & Co 872.01K sh · $30.29M · Q2 2026
- Goldman Sachs Group 853.72K sh · $29.66M · Q2 2026
- Point72 Asset Management 566.80K sh · $19.69M · Q2 2026
- Millennium Management 438.66K sh · $15.24M · Q2 2026
- UBS Group AG 438.59K sh · $15.24M · Q2 2026
- Balyasny Asset Management 395.45K sh · $13.74M · Q2 2026
- Northern Trust Corp 332.75K sh · $11.56M · Q2 2026